HEAL Data2Action Modeling and Economic Resource Center

HEAL Data2Action 建模和经济资源中心

基本信息

  • 批准号:
    10708099
  • 负责人:
  • 金额:
    $ 163.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-30 至 2027-08-31
  • 项目状态:
    未结题

项目摘要

The HEAL Data2Action (D2A) Program is a coordinated effort to promote the synthesis and real-world application of existing data to guide and monitor improvements in service delivery to prevent or treat opioid use disorder (OUD) and pain. Collectively, these projects will address gaps in the delivery of evidence-based practices in each of the four pillars of the HHS Overdose Prevention Strategy: primary prevention, harm reduction, treatment of opioid use disorder, and recovery support. The HEAL D2A Modeling and Economic Resource Center (MERC) will support the HEAL D2A Innovation Projects by providing expertise in simulation modeling and economic evaluation methods and will consult with the HEAL D2A Innovation Grant recipients on applying these methods and insights in their local implementation activities. The MERC will also conduct original research applying state-of-the-art economic and simulation modeling expertise to understand and address the overdose crisis. Since 2015, we have worked collaboratively to lead a highly successful multi- institutional NIDA-funded national center of excellence, the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH). We are thus uniquely qualified to lead the HEAL D2A MERC with the following aims: 1) to support the HEAL D2A Innovation Projects by providing methodological consultation on the application of rigorous modeling techniques, cost analyses, and behavioral economic strategies to support the projects' selection and implementation of evidence-based practices to address service delivery needs; 2) to develop tools that can be readily used by the Innovation Projects to make informed decisions about the relative costs of different implementation interventions to different stakeholders, to measure the overall costs of these efforts, and to inform the design of appropriate payment systems that support sustainability; 3) to use meta-modeling techniques to develop a user-friendly interface so that simulation model results generated for one system or community can be adapted for other systems/communities or adapted when local circumstances change; 4) to conduct novel research using advanced modeling and health economics approaches that build on existing data to provide insights into the complex dynamics of addressing the overdose crisis through strategic implementation of evidence-based practices. The HEAL D2A MERC will support the application of health economics and modeling research to real-world decision making about services to prevent or treat opioid use disorder and pain, will further scientific innovation in the field, and will establish a paradigm for integrating health economics and modeling into substance use treatment and prevention policies at the system level. The HEAL D2A MERC will be collaborative with the work of the HEAL D2A Research Adoption Support Center (RASC), including the consultations and catalog of measures and tools of the Implementation Support Cores, and will leverage and contribute to the resources of the HEAL D2A Data Infrastructure Support Center (DISC).
HEAL Data 2Action(D2 A)计划是一项协调努力,旨在促进综合和现实世界 应用现有数据指导和监测预防或治疗类阿片使用服务提供的改进 疾病(OUD)和疼痛。总的来说,这些项目将解决提供循证教育方面的差距, 在HHS过量预防战略的四大支柱中的每一个方面的做法:初级预防, 减少、治疗阿片类药物使用障碍和康复支持。HEAL D2 A建模与经济性 资源中心(MERC)将通过提供模拟方面的专业知识来支持HEAL D2 A创新项目 建模和经济评估方法,并将与HEAL D2 A创新补助金获得者协商, 将这些方法和见解应用于当地的执行活动。MERC还将进行 原创性研究应用最先进的经济和模拟建模专业知识,以了解和 解决吸毒过量危机。自2015年以来,我们共同努力,领导了一个非常成功的多- 机构NIDA资助的国家卓越中心,治疗卫生经济学中心 物质使用障碍,HCV和HIV的干预措施(CHERISH)。因此,我们有独特的资格领导 HEAL D2 A MERC具有以下目标:1)通过提供以下服务来支持HEAL D2 A创新项目 就严格的建模技术、成本分析和行为分析的应用提供方法论咨询。 支持项目选择和实施循证做法的经济战略, 满足服务提供需求; 2)开发创新项目可以随时使用的工具, 就不同实施干预措施对不同利益攸关方的相对成本作出知情决定, 衡量这些努力的总体成本,并为设计适当的支付系统提供信息, 支持可持续性; 3)使用元建模技术开发用户友好界面, 为一个系统或社区生成的仿真模型结果可以适用于其它系统或社区 系统/社区或适应当地情况的变化; 4)进行新的研究, 先进的建模和卫生经济学方法,建立在现有数据的基础上, 通过战略性实施循证药物管理解决药物过量危机的复杂动态 实践HEAL D2 A MERC将支持卫生经济学和建模研究的应用, 关于预防或治疗阿片类药物使用障碍和疼痛的服务的现实世界决策,将进一步科学 创新领域,并将建立一个范式,将卫生经济学和建模整合到 系统一级的药物使用治疗和预防政策。HEAL D2A MERC 与HEAL D2 A研究采用支持中心(RASC)的工作合作,包括 磋商和执行支助核心的措施和工具目录,并将利用和 为HEAL D2 A数据基础设施支持中心(DISC)提供资源。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Benjamin P. Linas其他文献

153: THE HEPATITIS C CARE CASCADE DURING THE DIRECT-ACTING ANTIVIRAL ERA WITHIN A NATIONALLY REPRESENTATIVE UNITED STATES HEALTH CLAIMS DATABASE
  • DOI:
    10.1016/s0016-5085(22)62685-4
  • 发表时间:
    2022-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Nicole Ferrante;Craig Newcomb;Charles Leonard;Jessie Torgersen;Sarah Rowan;Benjamin P. Linas;David L. Wyles;Jay Kostman;Kimberly A. Forde;Stacey Trooskin;Vincent Lo Re
  • 通讯作者:
    Vincent Lo Re
Publisher Correction: Long COVID impacts: the voices and views of diverse Black and Latinx residents in Massachusetts
  • DOI:
    10.1186/s12889-024-19890-z
  • 发表时间:
    2024-09-12
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Linda Sprague Martinez;Nihaarika Sharma;Janice John;Tracy A. Battaglia;Benjamin P. Linas;Cheryl R. Clark;Linda B. Hudson;Rebecca Lobb;Gillian Betz;Shayne Orion Ojala O’Neill;Angelo Lima;Ross Doty;Syeeda Rahman;Ingrid V. Bassett
  • 通讯作者:
    Ingrid V. Bassett
Primary Care Physicians’ Preparedness to Recognize and Evaluate Patients for Long COVID
  • DOI:
    10.1007/s11606-025-09387-9
  • 发表时间:
    2025-01-22
  • 期刊:
  • 影响因子:
    4.200
  • 作者:
    Nicole D. Kaufmann;Kathleen M. Mazor;Jai Marathe;Benjamin P. Linas;Kimberly A. Fisher
  • 通讯作者:
    Kimberly A. Fisher
Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19
COVID-19 住院患者的阿巴西普药代动力学和暴露反应
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    Stephen J. Balevic;Daniel K. Benjamin;W. G. Powderly;P. B. Smith;Daniel Gonzalez;Matthew W McCarthy;Linda K Shaw;C. J. Lindsell;Sam Bozzette;Daphne Williams;Benjamin P. Linas;J. Blamoun;H. Javeri;Christoph P. Hornik;Mahendra Patel;Arun J Sanyal;Jason Green;Huimin Wu;Benjamin P. Linas;Philip Grant;Vivek Iyer;Otto Yang;Bindu Balani;Sam Parnia;Ryan Dare;Caryn Morse;Estelle S. Harris;Glenn Wortmann;Nicholas Hill;Shama Patel;Julia Garcia;Suman Thapamager;Megan Devine;Christine M. Bojanowski;Barry Meisenberg;Gailen Marshall;D. Dandachi;Arick Sabin;Anthony Breemo;Suman Sinha;Christopher Goss;Rebecca Reece;Arlette Aouad;Seth Glassman;Peter Morris;Bela Patel;Fatimah Bello;Juliana Cardozo Fernandes;Oscar Carbajal;L. Ravera;Mozar Castro;Miguel Villegas;Fernando Oscar Riera;Adrian Camacho;Claudio Stadnik;Jorge Gave;Rodrigo Biondi;Ronal Gamarra Velarde;José Cerbino Neto;J. Ditondo;Marcelo H. Losso;Mariano Dolz;Alexandra O’Sullivan;Brian Gavin;M. Beumont‐Mauviel;Huyen Ca;R. Beci;Daniel Molina;Sandhya Rao;Thomas Stock;William Erhardt;Sarah Read;Jessica Springer;Rachel Presti;Ryley Thompson;Kimberly Gray;Cathy Henry;Alem Haile;Michael Klebert;L. Kessels;Kathryn Vehe;Kristopher Bakos;Teresa Spitz;Sara Hubert;Raghd Alyatim;Brittany Schneider;Chapelle A Ayres;A. Spec;L. Blair;Anita Afghanzada;Natalie Schodl;L. Wahid;John J. Engemann;Gloria Pinero;Beth McLendon;Lynn Whitt;Jenny Shroba;Elizabeth Salsgiver;Candace Alleyne;Anna Gwak;Nicholas Pickell;Jack Spagnoletti;Samson Goh;Katharine Robb;Michael Cenname;Catherine Small;Markus Plate;Rodrigo Burgos;Brenna Lindsey;Fischer Herald;Stephanie Echeverria;Dorendra Lewis;Mahesh Patel;Charles D. Bengtson;Andreas Schmid;Kimberly Lovell;C. Lovelett;Daniel Soule;Daniel Jaremczuk;Jennie Flanagan;Cameron Murray;Kylie Sands;Kyle Flint;Sara Mohaddes;Caryn Harrington;Kylie Broughal;David Sogoian;Karen Cox;H. Javeri;Philip O. Ponce;D. O. Dixon;Jason E. Bowling;Jan E. Patterson;Barbara S. Taylor;Ruth C. Serrano;Kaylin Sallee;Robin E Tragus;Gabriel Catano;Irma Scholler;Rose Ann Barajas;Armando Garcia;Bridgette T. Soileau;Patricia Heard;Manuel Camilo Endo Carvajal;Rukevwe Ehwarieme;Divya Chandramohan;Alejandro Cabo;Abdelhameed Nawwar;C. Quill;Nayeem Choudhury;Ashley Arrington;Isaiah Holyfield;Abby Smith;Glenda Brown;Kyle Varner;Joni Baxter;Tracy Roundy;Mary Co;Mireya Wessolossky;Juan Perez;Jennifer Holter;Brittany Karfonta;Juvaria Anjum;Jai Marathe;Myriam Castagne;D. Mompoint;Ryan Schroeder;Mallika Rao;Johnathan Nguyen;J. Plewa;Sue Donlinger;Marylynn Breslin;S. Dodson;Mitch Jenkins;John Williamson;E. Middleton;Mai Tavadze;Romai Sebhatu;Jessica Pierobon;Nate Miller;John Lee;Pratik Doshi;Andrew Dentino;Jessica Martin;Erik Hinojosa;Pablo Torres;Ricardo Sanchez;Gladys Murga;Silvana de la Gala;Jhon Chaiña;Jorge Ramos;Jenny Malca;Kathia Castillo;Johana Calderon Galvez;Maria Lyda Icochea Perez;Claudia Carolina Becerra Nunez;Sandra Betteta Riondato;Sandra Delgado Málaga;Cecilia Barreda Sánchez;Sylvia Sánchez Morales;Myriam Yaringano Palacios;Dora Galarza Cuba;Ivan Hermenegildo;Mayra Falla Benites;Stefania Neyra;Josefina Hernández;Victoria García;Katherine Palacios;Miluska Matos;Fiorella Zuloeta;Fiorella del Carpio;Gloria Chacaltana;Carmen de la Cruz;Felipe Ceriolli Breda;Mauricio Mello Roux Leite;T. Milbradt;Luz Rodeles;Nadia Benzaquen;Sebastian Pezzini;Lucila Alberdi;P. Serravalle;Giulia Russo;F. Ferini;M. Guala;Alejandro Crespo;Agostina Benitez;Maria Elena Cristaldi;Paula Di Renzo;Corina Gramagalia;Antonela Tessini;Joana Evelin Alonso;Carmen Pic;Georgina Ceraldi;Azucena Mondino;Iliana Higareda Almaraz;Víctor Hugo Madrigal Robles;María Fernanda Rosas Ismerio;Maria Fernanda Rodarte Rodriguez;Norma Esther Olmos Meza;Norma Esther de la Cruz Barba;Ana Maria Alba Ponce;Juan Manuel Calderon;Eduardo Borsetta;Noemí Sandoval;Daniela Vazquez;Malena Mansilla;Marta Molina;Yamila Jara;Laura De Bona;Maria Eduarda Claus;Arthur Pille;M. Lahitte;Mariángeles Fenés;Cecilia Bianchi;María Emilia Miserere;M. F. Alzogaray;Halbert Christian Sanchez Carrillo;Aldana Mano;Myrna Zuain;J. Toibaro;Valeria Pachioli;Sebastián Chaio;Natalia Malamud;D. Bharucha;Patrick B. Dorr;Jonathan Sadeh;Sheila Kelly;Marita Stevens;Huyen Cao;Adam DeZure;K. Juneja;Mazin Abdelghany;Theresa Jasion;Rachel E. Olson;Megan Roebuck;J. Huvane;C. J. Lindsell;Jeff Leimberger;Eric Yow;Zhen Huang;Hwasoon Kim;Carla Anderson;Carrie Elliott;Merri Swartz;Jyotsna Garg;Neta Nelson;Divya Kalaria;Ketty Philogene;Tim Schulz;Averie Kuek;Fatou Bah;Jarrard Mitchell;Elizabeth Polo;Michelle Wong;Sharon Baldan;Sandra Mendez;Bradford Stevens;Marcela Toledo;Talita Abba;Emma Herrejon;Cristina Gomez;Georgeta Mardari;Neeraja Putta;Robin Mason;Holli Hamilton;Derek Eisnor;Anna O’Rourke;Aditi Patel;Betty Brody;Anna Chiang;Brian Lind;Lilli M. Portilla;Ami D. Gadhia;Sury Vepa;Emily Carlson Marti;Bobbi Gardner;J. Rutter;Clare Schmitt;Michael Kurilla
  • 通讯作者:
    Michael Kurilla
T84 - Health and Economic Outcomes of Offering Buprenorphine in Shelters in Massachusetts: Results of a Simulation Model
T84 - 马萨诸塞州庇护所提供丁丙诺啡的健康和经济结果:模拟模型的结果
  • DOI:
    10.1016/j.drugalcdep.2024.111852
  • 发表时间:
    2025-02-01
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Emily Stewart;Avik Chatterjee;Sabrina A. Assoumou;Stavroula A. Chrysanthopoulou;Rebecca Arden Harris;Ryan O'Dea;Bruce Schackman;Laura White;Benjamin P. Linas
  • 通讯作者:
    Benjamin P. Linas

Benjamin P. Linas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Benjamin P. Linas', 18)}}的其他基金

HEAL Data2Action Modeling and Economic Resource Center
HEAL Data2Action 建模和经济资源中心
  • 批准号:
    10590443
  • 财政年份:
    2022
  • 资助金额:
    $ 163.22万
  • 项目类别:
Researching Effective Strategies to Prevent Opioid Death (RESPOND)
研究预防阿片类药物死亡的有效策略(RESPOND)
  • 批准号:
    10804924
  • 财政年份:
    2018
  • 资助金额:
    $ 163.22万
  • 项目类别:
Researching Effective Strategies to Prevent Opioid Death (RESPOND)
研究预防阿片类药物死亡的有效策略(RESPOND)
  • 批准号:
    10369647
  • 财政年份:
    2018
  • 资助金额:
    $ 163.22万
  • 项目类别:
Researching Effective Strategies to Prevent Opioid Death (RESPOND)
研究预防阿片类药物死亡的有效策略(RESPOND)
  • 批准号:
    9891990
  • 财政年份:
    2018
  • 资助金额:
    $ 163.22万
  • 项目类别:
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care
模拟建模改善 HIV/HCV 筛查、治疗和护理
  • 批准号:
    8846562
  • 财政年份:
    2012
  • 资助金额:
    $ 163.22万
  • 项目类别:
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care
模拟建模改善 HIV/HCV 筛查、治疗和护理
  • 批准号:
    8263169
  • 财政年份:
    2012
  • 资助金额:
    $ 163.22万
  • 项目类别:
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care
模拟建模改善 HIV/HCV 筛查、治疗和护理
  • 批准号:
    8662217
  • 财政年份:
    2012
  • 资助金额:
    $ 163.22万
  • 项目类别:
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care
模拟建模改善 HIV/HCV 筛查、治疗和护理
  • 批准号:
    8862651
  • 财政年份:
    2012
  • 资助金额:
    $ 163.22万
  • 项目类别:
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care
模拟建模改善 HIV/HCV 筛查、治疗和护理
  • 批准号:
    8486407
  • 财政年份:
    2012
  • 资助金额:
    $ 163.22万
  • 项目类别:
Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs
改善美国艾滋病药物援助计划中的艾滋病毒和丙型肝炎治疗结果
  • 批准号:
    7339148
  • 财政年份:
    2007
  • 资助金额:
    $ 163.22万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 163.22万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 163.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 163.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 163.22万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 163.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 163.22万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 163.22万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 163.22万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 163.22万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 163.22万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了